Literature DB >> 3429787

Cytosolic and nuclear androgen receptor activity in the cancer of the larynx.

M Marugo1, G Cordone, L Fazzuoli, O Rocchetti, D Bernasconi, C Laviosa, D Bessarione, G Giordano.   

Abstract

It is well known that the larynx is a target organ for androgens and the cancer of larynx is more frequent in male subjects. We have evaluated the androgen receptors (AR) in the cytosol (ACR) and in salt extractable (ANR) and salt resistant nuclear fraction (AMR) in a group of 24 male patients with cancer of the larynx surgically removed. In addition specimens obtained from the normal mucosa of the same subjects were analyzed. In 5 patients estrogen (ER) and progesterone (PgR) receptors were also assayed. In all subjects blood samples were taken before surgery for the assay of the following hormones: LH, FSH, estradiol, testosterone, dihydrotestosterone, delta 4-androstenedione, dehydroepiandrosterone sulfate, cortisol. The results observed showed that 18 out of 24 normal larynx mucosa specimens and 17 out of 24 larynx cancer specimens were positive for ACR or ANR or AMR. The 5 samples of normal and cancer tissues analyzed for ER and PgR were negative. In conclusion there is no significant correlation between AR positivity from one size, histology, degree of differentiation and invasivity of the cancer, age of patients and hormonal blood levels from the other. The high ANR and AMR positivity (normal hormonal translocation and binding on DNA acceptors) confirm that the normal and cancer larynx are target tissue for androgens and establish the hormone dependence of this cancer. Hormonal therapy could be envisaged as an alternative or a complementary therapy for this type of cancer at least in the cases in which the analysis of hormone receptors will prove to be positive.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3429787     DOI: 10.1007/BF03348171

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  6 in total

1.  Androgen receptors in human pharyngo-laryngeal mucosa and pharyngo-laryngeal epithelioma.

Authors:  S Saez; F Sakai
Journal:  J Steroid Biochem       Date:  1976 Nov-Dec       Impact factor: 4.292

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Standards for the assessment of estrogen receptors in human breast cancer. Report of a workshop on September 29, 1972, at the Antoni van Leeuwenhoek-Huis, Amsterdam.

Authors: 
Journal:  Eur J Cancer       Date:  1973-05       Impact factor: 9.162

4.  Plasma testosterone levels following surgical stress in male patients.

Authors:  K Matsumoto; K Takeyasu; S Mizutani; Y Hamanaka; T Uozumi
Journal:  Acta Endocrinol (Copenh)       Date:  1970-09

5.  Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.

Authors:  E R Barrack; P Bujnovszky; P C Walsh
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

6.  Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute.

Authors: 
Journal:  Eur J Cancer       Date:  1980-11       Impact factor: 9.162

  6 in total
  5 in total

1.  Anatomical variation of the oestrogen receptor in the non-neoplastic myometrium of fibromyomatous uteri.

Authors:  P A Richards; A J Tiltman
Journal:  Virchows Arch       Date:  1996-08       Impact factor: 4.064

2.  [The effect of hormonal agents on the development of chronic laryngitis and tumor disease. Report of two cases].

Authors:  D Kleemann; B Stengel
Journal:  HNO       Date:  2010-03       Impact factor: 1.284

3.  Anatomical variation of the oestrogen receptor in normal myometrium.

Authors:  P A Richards; A J Tiltman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Thyroid and steroid receptors.

Authors:  M Marugo; G Torre; D Bernasconi; L Fazzuoli; S Berta; G Giordano
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

5.  Androgen receptor in laryngeal carcinoma: could there be an androgen-refractory tumor?

Authors:  Anastasios K Goulioumis; John Varakis; Panos Goumas; Helen Papadaki
Journal:  ISRN Oncol       Date:  2011-11-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.